Effect of oversized partial postdilatation on coatings of contemporary durable polymer-based drug-eluting stents: A scanning electron microscopy study

Journal of Interventional Cardiology

Volumn 24, Issue 2, 2011, Pages 149-161

  Basalus, Mounir W Z ^a   Tandjung, Kenneth ^a   Van Apeldoorn, Aart A ^b   Ankone, Marc J K ^b   Von Birgelen, Clemens ^a,b  

^a Thoraxcentrum Twente ^*  (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

POLYMER;

ARTICLE; BALLOON DILATATION; CLASSIFICATION; DRUG ELUTING STENT; MATERIAL COATING; MICROSCOPE IMAGE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THICKNESS;

ANGIOPLASTY, BALLOON, CORONARY; DRUG-ELUTING STENTS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; POLYMERS; PROSTHESIS DESIGN;

EID: 79953759463     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2010.00617.x     Document Type: Article

References (31)

1. Grube E, Silber S, Hauptmann KE, et al. TAXUS I: Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003;107:38-42. (Pubitemid 36070930)
2. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780. (Pubitemid 34586912)
3. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323. (Pubitemid 37186209)
4. Romagnoli E, Sangiorgi GM, Cosgrave J, et al. Drug-eluting stenting: The case for post-dilation. JACC Cardiovasc Interv 2008;1:22-31.
5. Hong MK, Park SW, Mintz GS, et al. Intravascular ultrasonic predictors of angiographic restenosis after long coronary stenting. Am J Cardiol 2000;85:441-445. (Pubitemid 30089618)
6. Kim SW, Mintz GS, Escolar E, et al. An intravascular ultrasound analysis of the mechanisms of restenosis comparing drug-eluting stents with brachytherapy. Am J Cardiol 2006;97:1292-1298.
7. Takebayashi H, Kobayashi Y, Mintz GS, et al. Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation. Am J Cardiol 2005;95:498-502. (Pubitemid 40247548)
8. Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007;115:2426-2434. (Pubitemid 46717965)
9. Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study. J Am Coll Cardiol 2005;45:995-998. (Pubitemid 40432428)
10. Uren NG, Schwarzacher SP, Metz JA, et al. Predictors and outcomes of stent thrombosis: An intravascular ultrasound registry. Eur Heart J 2002;23:124-132. (Pubitemid 35204230)
11. Jeremias A, Kirtane A. Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention. Ann Intern Med 2008;148:234-238. (Pubitemid 351665508)
12. Mehran R, Dangas GD. Off-label use of drug-eluting stents:Assessing the risk. Nat Clin Pract Cardiovasc Med. 2007;4:594-595. (Pubitemid 350020366)
13. Basalus MW, van Houwelingen GK, Ankone MJ, et al. Microcomputed tomographic assessment following extremely oversized partial postdilatation of drug-eluting stents. Eurointervention 2010;6:141-148.
14. Basalus MW, von Birgelen C. Bench side testing of drug-eluting stent surface and geometry. Intervent Cardiol 2010;2:159-175.
15. Serruys PW, Regar E, Carter AJ. Rapamycin eluting stent: The onset of a new era in interventional cardiology. Heart 2002;87:305-307. (Pubitemid 34270933)
16. FDA summary of safety and effectiveness data of Taxus Liberté. 2008;P060008. http://www.accessdata.fda.gov/cdrh-docs/pdf6/P060008S011b.pdf. Accessed on 30-11-2010.
17. Pinto Slottow TL,Waksman R. Overview of the 2007 food and drug administration circulatory system devices panel meeting on the endeavor zotarolimus-eluting coronary stent. Circulation 2008;117:1603-1608.
18. Meredith IT, Worthley S, Whitbourn R, et al. The next-generation Endeavor Resolute stent: 4-month clinical and angiographic results from the Resolute first-in-man trial. EuroIntervention 2007;3:50-53.
19. Stone GW, Midei M, Newman W, et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: A randomized trial. JAMA 2008;299:1903-1913. (Pubitemid 351574920)
20. BasalusMW, Ankone MJ, van Houwelingen GK, et al. Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy. EuroIntervention 2009;5:157-165.
21. Basalus MW, van Houwelingen KG, Ankone M, et al. Scanning electron microscopic assessment of the biodegradable coating on expanded biolimus-eluting stents. EuroIntervention 2009;5:505-510.
22. Ormiston J, Webster M, Ruygrok P, et al. Polymer integrity after Cypher and Taxus stent implantation: A scanning electron microscope study. 2004; http://www.tctmd.com/show.aspx?id=58632. Accessed on June 28, 2010.
23. Otsuka Y, Chronos NA, Apkarian RP, et al. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: Comparison of BiodivYsio, Taxus and Cypher stents. J Invasive Cardiol 2007;19:71-76.
24. Brodie BR, Cooper C, Jones M, et al. Is adjunctive balloon postdilatation necessary after coronary stent deployment? Final results from the POSTIT trial. Catheter Cardiovasc Interv 2003;59:184-192. (Pubitemid 36665948)
25. De Benedetti E, Urban P. Coronary stenting: Why size matters. Heart 2007;93:1500-1501. (Pubitemid 350205532)
26. Aziz S, Morris JL, Perry RA, Stables RH. Stent expansion: A combination of delivery balloon underexpansion and acute stent recoil reduces predicted stent diameter irrespective of reference vessel size. Heart 2007;93:1562-1566. (Pubitemid 350205550)
27. Brodie BR. Adjunctive balloon postdilatation after stent deployment: Is it still necessary with drug-eluting stents? J Interv Cardiol 2006;19:43-50.
28. Erbel R, Di Mario C, Bartunek J, et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: A prospective, non-randomised multicentre trial. Lancet 2007;369:1869-1875. (Pubitemid 46829357)
29. Serruys PW, Ormiston JA, Onuma Y, et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009;373:897-910.
30. Wiemer M, Butz T, Schmidt W, et al. Scanning electron microscopic analysis of different drug eluting stents after failed implantation: From nearly undamaged to major damaged polymers. Catheter Cardiovasc Interv 2010;75:905-911.
31. von Birgelen C, Basalus MW. On the loss of the phosphorylcholine-based DES coating on the abluminal surface of endeavor stents. Catheter Cardiovasc Interv 2010;76:158-159.